Xiaoliang Wang
- Epidemiology top 5%
- Adipokines, Inflammation, and Metabolic Diseases 12
- Liver Disease Diagnosis and Treatment 11
-
- Cardiovascular Disease and Adiposity 7
- Physiology top 5%
- Adipose Tissue and Metabolism 11
- Alzheimer's disease research and treatments 6
- Neurology top 10%
- Behavioral Neuroscience top 10%
-
- Cancer-related molecular mechanisms research 5
- Cancer, Hypoxia, and Metabolism 4
-
- Epigenetics and DNA Methylation 4
- Co-authors
- Wayne Bond LauYajing WangErhe GaoWalter J. KochYuexing YuanXinliang MaWei YiYang Sun
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Xiaoliang Wang
71 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 106
- Epidemiology 673
- Cardiology and Cardiovascular Medicine 441
- Physiology 435
- Neurology 91
- Behavioral Neuroscience 37
Countries citing papers authored by Xiaoliang Wang
This map shows the geographic impact of Xiaoliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoliang Wang more than expected).
Fields of papers citing papers by Xiaoliang Wang
This network shows the impact of papers produced by Xiaoliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoliang Wang. The network helps show where Xiaoliang Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoliang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 9 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 25 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 13 | |
| 13 | 2020 | 2 | |
| 14 | 2019 | 31 | |
| 15 | 2018 | 17 | |
| 16 | [Progress of clinical trials in Alzheimer’s disease drugs]. | 2016 | 1 |
| 17 | 2012 | 98 | |
| 18 | 2011 | 1 | |
| 19 | 2010 | 53 | |
| 20 | Abstract 14133: CTRPs, A Novel Therapeutic Target Against Myocardial Ischemia/Reperfusion Injury | 2010 | 1 |
About Xiaoliang Wang
Xiaoliang Wang is a scholar working on Epidemiology, Physiology and Cancer Research, having authored 75 papers that have together received 1.8k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (12 papers), Adipose Tissue and Metabolism (11 papers), Liver Disease Diagnosis and Treatment (11 papers), Cardiovascular Disease and Adiposity (7 papers), Alzheimer's disease research and treatments (6 papers), Cancer-related molecular mechanisms research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Epidemiology (673 citations), Cardiology and Cardiovascular Medicine (441 citations) and Physiology (435 citations). Xiaoliang Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Wayne Bond Lau, Yajing Wang, Erhe Gao, Walter J. Koch, Yuexing Yuan, Xinliang Ma, Wei Yi, Yang Sun, Qijun Zheng and Ling Wang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.